Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Karuna Therapeutics, Inc.    KRTX

KARUNA THERAPEUTICS, INC.

(KRTX)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news

KARUNA THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/18/2019 | 06:07am EST

Item 8.01 Other Events.

On November 18, 2019, Karuna Therapeutics, Inc. (the "Company") announced results from its Phase 2 clinical trial of KarXT for the treatment of acute psychosis in patients with schizophrenia. A copy of this press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The presentation containing the initial data from the Phase 2 clinical trial is attached hereto as Exhibit 99.2 and is incorporated by reference herein.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits



99.1      Press Release issued by Karuna Therapeutics, Inc., dated November 18,
        2019.

99.2      Company presentation, dated November 18, 2019.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on KARUNA THERAPEUTICS, INC.
01/23PureTech Health Cuts Karuna Therapeutics Stake to 20.4%
DJ
01/09KARUNA THERAPEUTICS : to Present at the 38th Annual J.P. Morgan Healthcare Confe..
BU
2019KARUNA THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
2019KARUNA THERAPEUTICS : to Present at the Piper Jaffray 31st Annual Healthcare Con..
BU
2019KARUNA THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (for..
AQ
2019KARUNA THERAPEUTICS : Announces Pricing of $250 Million Public Offering of Commo..
BU
2019LONDON STOCK EXCHANGE : FTSE up for third day on China stimulus hopes, Halma jum..
RE
2019KARUNA THERAPEUTICS : Announces Proposed Public Offering of Common Stock
BU
2019KARUNA THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (for..
AQ
2019KARUNA THERAPEUTICS : Announces KarXT Met Primary Endpoint in Phase 2 Clinical T..
BU
More news